Bexarotene
- Product NDC
- 43975-315
- 11-digit product format
- 439750315
- Labeler code
- 43975
- Product ID
- 43975-315_07544503-a705-48cb-9a86-5bb5ece3fb91
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bexarotene
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- ANI Pharmaceuticals, Inc.
- Application
- ANDA209861
- Marketing category
- ANDA
- Marketing start
- 2018-05-10
- Substance
- BEXAROTENE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bexarotene
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BEXAROTENE | 75 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | A61RXM4375 |
| Rxcui | 308725 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43975-315-10 | Bexarotene | 100 in 1 BOTTLE | CAPSULE, LIQUID FILLED | 100 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43975-315 | BEXAROTENE CAPSULE, LIQUID FILLED [ANI PHARMACEUTICALS, INC.] | 7 | Current NDC, Legacy NDC, 1 package rows | 20241129_e713c60d-f623-4260-b0ca-db07e1365fd2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43975-315-10 | 43975031510 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (43975-315-10) | 2018-05-10 | 0000-00-00 | No | No | Current |